Evidence map›Paper›PMID 37393090›Full record

ArticleThe Lancet. Public health2023

Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis.

Leonardo Martinez, Joshua L Warren, Anthony D Harries, Julio Croda, Marcos A Espinal, Rafael A López Olarte, Pedro Avedillo, Christian Lienhardt, Vineet Bhatia, Qiao Liu and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in The Lancet. Public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 9 countries.

Leonardo MartinezDepartment of Epidemiology, School of Public Health, Boston University, Boston, MA, USA. Electronic address: leomarti@bu.edu.
Joshua L WarrenDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Anthony D HarriesFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; International Union Against Tuberculosis and Lung Disease, Paris, France.
Julio CrodaSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil; Oswaldo Cruz Foundation, Mato Grosso do Sul, Brazil.
Marcos A EspinalPan American Health Organization, Communicable Diseases and Environmental Determinants of Health, Washington, DC, USA.
Rafael A López OlartePan American Health Organization, Communicable Diseases and Environmental Determinants of Health, Washington, DC, USA.
Pedro AvedilloPan American Health Organization, Communicable Diseases and Environmental Determinants of Health, Washington, DC, USA.
Christian LienhardtUnité Mixte Internationale Trans VIHMI (UMI 233 IRD-U1175 INSERM, Université de Montpellier), Institut de Recherche pour le Développement, Montpellier, France.
Vineet BhatiaDepartment of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, India.
Qiao LiuDepartment of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China.
Jeremiah ChakayaDepartment of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Justin T DenholmVictorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Australia; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, Australia.
Yan LinInternational Union Against Tuberculosis and Lung Disease, Paris, France.
Lisa KawatsuDepartment of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Tokyo, Japan.
Limei ZhuDepartment of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China.
C Robert HorsburghDepartment of Epidemiology, School of Public Health, Boston University, Boston, MA, USA; Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Jason R AndrewsDivision of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
World Health Organization Regional Office for the Americas · USBoston University · USInternational Union Against Tuberculosis and Lung Disease · FRJiangsu Provincial Center for Disease Control and Prevention · CNYale University · USInstitut de Recherche pour le Développement · FRJapan Anti Tuberculosis Association · JPKenyatta University · KEStanford University · USUniversidade Federal de Mato Grosso do Sul · BRUniversity of Melbourne · AUWorld Health Organization Regional Office for South-East Asia · IN

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Strategies for tuberculosis control in prisonsR01AI130058 · NIAID · STANFORD UNIVERSITY · PI Jason Randolph Andrews, Julio Henrique Rosa Croda · 2017 to 2026
$5.8M
Predicting and monitoring variations in the effects of vaccines against RSVR01AI137093 · NIAID · YALE UNIVERSITY · PI Virginia E Pitzer, Daniel Martin Weinberger · 2018 to 2026
$3.4M
Identifying effective and efficient approaches to tuberculosis screening in BrazilianprisonsK01AI156022 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MARTINEZ, LEONARDO · 2021 to 2025
$640k
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmissionR01AI149620 · NIAID · STANFORD UNIVERSITY · PI ANDREWS, JASON RANDOLPH, CRODA, JULIO · 2020 to 2023
$617k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS K01 AI156022NIAID NIH HHS R01 AI130058NIAID NIH HHS R01 AI137093NIAID NIH HHS R01 AI149620World Health Organization 001
6 · The paper itself

Abstract

backgroundPeople who are incarcerated are at high risk of developing tuberculosis. We aimed to estimate the annual global, regional, and national incidence of tuberculosis among incarcerated populations from 2000 to 2019.

methodsWe collected and aggregated data for tuberculosis incidence and prevalence estimates among incarcerated individuals in published and unpublished literature, annual tuberculosis notifications among incarcerated individuals at the country level, and the annual number of incarcerated individuals at the country level. We developed a joint hierarchical Bayesian meta-regression framework to simultaneously model tuberculosis incidence, notifications, and prevalence from 2000 to 2019. Using this model, we estimated trends in absolute tuberculosis incidence and notifications, the incidence and notification rates, and the case detection ratio by year, country, region, and globally.

findingsIn 2019, we estimated a total of 125 105 (95% credible interval [CrI] 93 736-165 318) incident tuberculosis cases among incarcerated individuals globally. The estimated incidence rate per 100 000 person-years overall was 1148 (95% CrI 860-1517) but varied greatly by WHO region, from 793 (95% CrI 430-1342) in the Eastern Mediterranean region to 2242 (1515-3216) in the African region. Global incidence per 100 000 person-years between 2000 and 2012 among incarcerated individuals decreased from 1884 (95% CrI 1394-2616) to 1205 (910-1615); however, from 2013 onwards, tuberculosis incidence per 100 000 person-years was stable, from 1183 (95% CrI 876-1596) in 2013 to 1148 (860-1517) in 2019. In 2019, the global case detection ratio was estimated to be 53% (95% CrI 42-64), the lowest over the study period.

interpretationOur estimates suggest a high tuberculosis incidence rate among incarcerated individuals globally with large gaps in tuberculosis case detection. Tuberculosis in incarcerated populations must be addressed with interventions specifically tailored to improve diagnoses and prevent transmission as a part of the broader global tuberculosis control effort.

fundingNational Institutes of Health.

Indexed as

PrisonersTuberculosisBayes TheoremHumansIncidenceUnited States

Identifiers

PMID37393090
PMCPMC10323309
OpenAlexW4382601679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.